BOTULAX® 300u

BOTULAX® 300u is a purified botulinum toxin type A formulation manufactured by Hugel, Inc. in South Korea, supplied as a 300-unit powder vial requiring reconstitution before administration. BOTULAX® 300u is used for wrinkle reduction or therapeutic applications, acting by temporarily blocking acetylcholine release at the neuromuscular junction in the treatment area. Licensed professionals seeking to buy BOTULAX® 300u online for permitted professional use are encouraged to contact Doctor Medica's staff for sourcing guidance and documentation support.

Product Specifications

• Active Substance: Purified Clostridium botulinum toxin type A
• Strength: 300 units, or 300u
• Dosage Form: Powder for reconstitution
• Package Content: 1 x 300u vial, powder
• Manufacturer: Hugel, Inc.
• Country of Origin: South Korea
• Brand: BOTULAX®
• Therapeutic Applications: Wrinkle reduction; therapeutic applications per clinical context
• Weight: 26 grams
• Dimensions: Width: 50 mm | Height: 80 mm | Length: 40 mm

What Is BOTULAX® 300u?

BOTULAX® is a brand of botulinum toxin type A from Hugel, Inc., a South Korean company specializing in medical aesthetics and pharmaceutical biologics. [5] Regulatory filings for BOTULAX® presentations identify the active ingredient as Clostridium botulinum toxin type A, with the CBFC26 strain associated with BOTULAX® formulations registered in Korea. [4] For licensed healthcare professionals managing larger treatment areas, multi-zone protocols, or therapeutic applications that require careful unit allocation, the 300u vial size is well-suited to planned clinical use. Unit requirements should always be determined by the treating practitioner based on anatomy, clinical indication, muscle strength, the treatment area being addressed, and the applicable product guidance for the jurisdiction. BOTULAX® 300u is supplied as a lyophilized powder that must be reconstituted with sterile saline prior to injection. As a potent biologic medicine, preparation and administration are restricted to trained, licensed healthcare professionals who follow the manufacturer's instructions, applicable pharmaceutical regulations, and clinic protocols governing sterile preparation. In professional aesthetic practice, BOTULAX® is associated with dynamic facial wrinkle reduction. Dynamic wrinkles develop over time as a result of repeated muscle contractions, producing visible expression lines. Botulinum toxin type A temporarily reduces targeted muscle activity, which may soften treatment-area lines when administered correctly by a qualified practitioner. [2]

Mechanism of Action

BOTULAX® 300u exerts its effect by temporarily inhibiting acetylcholine release at the presynaptic neuromuscular junction, producing controlled, reversible relaxation of targeted muscles in the treatment area. [1] This mechanism supports wrinkle reduction in dynamic facial lines — including glabellar, forehead, and periocular lines — and underpins therapeutic applications in which a reduction in muscle activity is clinically indicated. [2] The neuromuscular effect is temporary and reversible. Clinical effect generally begins within days of injection and typically lasts about 3–4 months, depending on individual patient response and local clinical protocols. [1] Following reconstitution, dilution ratios govern the final unit concentration per milliliter. While a dilution chart can serve as a reference, specific dilution protocols and storage windows remain dependent on institutional guidelines and individual practitioners' judgment.

Indications and Therapeutic Applications

BOTULAX® 300u is for use by licensed healthcare professionals in clinical contexts where botulinum toxin type A treatment is professionally and regulatorily appropriate. In aesthetic medicine, treatment areas commonly addressed include dynamic facial lines arising from repetitive muscle contraction — notably glabellar lines, horizontal forehead lines, and crow's feet — with the therapeutic objective of controlled wrinkle reduction. [2] Botulinum toxin type A products, as a class, have been studied and in some jurisdictions authorized for a range of therapeutic applications beyond cosmetic use, including conditions involving excessive or pathological muscle activity and certain movement disorders. [3] BOTULAX®-specific indications are subject to country-specific labeling and local regulatory authorization. Licensed practitioners must verify which indications are approved for BOTULAX® 300u in their jurisdiction using current regulatory documentation before clinical use. [4] Prior to treatment, practitioners should conduct a thorough patient assessment that covers anatomical features, neuromuscular history, current medications, contraindication screening, and treatment expectations. Informed consent documentation should address expected onset, typical duration, potential adverse effects, and the likelihood of maintenance injections. Administration must be restricted to licensed professionals with demonstrated training in the use of botulinum toxin.

Reconstitution and BOTULAX® 300 Dilution Guidelines

The dilution of BOTULAX® 300 is a clinical preparation step that requires professional judgment. The powder vial is reconstituted with sterile 0.9% saline prior to use, and the resulting concentration depends on the diluent volume selected. A reduced diluent volume produces a more concentrated solution; a greater diluent volume yields a less concentrated preparation. In practice, dilution ratios are adjusted according to treatment area, muscle mass, desired diffusion, injection technique, and the intended therapeutic outcome. While a dilution chart can serve as a reference, specific dilution protocols and storage windows remain dependent on institutional guidelines and individual practitioners' judgment. Practitioners should confirm the exact storage timeframe and handling requirements from the current package insert or authorized product documentation rather than treating any chart-based reference as a universal standard. Safe reconstitution requires rigorous aseptic technique. The vial should be visually inspected before preparation, the diluent confirmed as appropriate for injection use, the stopper disinfected prior to needle entry, and the reconstituted solution handled carefully to prevent foaming, microbial contamination, or dosing inaccuracies.

Safety and Considerations

BOTULAX® 300u contains purified botulinum toxin type A and must be prepared and administered exclusively by licensed healthcare professionals. Safe clinical use depends on appropriate patient selection, accurate dilution, correct unit dosing, sound anatomical knowledge, and strict aseptic technique. [1][2] Reported reactions associated with botulinum toxin type A injections may include localized redness, swelling, bruising, tenderness, headache, temporary heaviness at the treatment site, facial asymmetry, or unintended muscle weakness in adjacent structures. Serious adverse events are uncommon but may include systemic toxin spread, presenting as difficulty swallowing, speech impairment, respiratory compromise, or generalized muscle weakness. [1] Contraindications typically include hypersensitivity to botulinum toxin or any formulation component, active infection at the proposed injection site, and known neuromuscular disorders. Any condition in which neuromuscular blockade may present an added clinical risk warrants careful evaluation prior to treatment.

Legal Status and Regulatory Information

BOTULAX® is manufactured by Hugel, Inc. in South Korea. [5] Regulatory filings classify BOTULAX® products as biological drug products containing Clostridium botulinum toxin type A, with indications registered for specified BOTULAX® presentations in Korea. [4] Regulatory status varies significantly by jurisdiction. Licensed practitioners must confirm whether BOTULAX® 300u is authorized in their specific market before procurement or clinical use. Requirements may differ across countries regarding product registration, import authorization, prescription classification, storage mandates, and mandatory training standards. Practitioners reviewing BOTULAX® 300u procurement options should independently verify local regulatory requirements, confirm authorized sourcing channels, inspect package integrity and storage documentation, and review current product labeling before clinical use.

Where Can Licensed Professionals Buy BOTULAX® 300u Online?

Licensed healthcare professionals looking to buy BOTULAX® 300u wholesale should approach procurement with the same standards applied to any regulated biologic: sourcing through channels that support full documentation, lot traceability, and cold-chain verification. When buying online, practitioners should confirm that the supplier provides a certificate of analysis, verifiable LOT numbers, documented storage history, and current regulatory authorization for the target jurisdiction. Professionals who check for wholesale buying options through qualified channels reduce the risk of sourcing compromised, mislabeled, or improperly stored product. Doctor Medica's staff can provide guidance on documentation expectations, supplier standards, and professional account support for practitioners looking to buy BOTULAX® through verified channels. Contact Doctor Medica's staff directly to discuss procurement context, professional eligibility, and available documentation resources.

References

[1] Nigam PK, Nigam A. Botulinum toxin. Indian Journal of Dermatology. 2010. https://pmc.ncbi.nlm.nih.gov/articles/PMC2856357/ [2] Nestor MS, Arnold D, Fischer DL. The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II. Journal of Cosmetic Dermatology. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7693297/ [3] Camargo CP, Xia J, Costa CS, et al. Botulinum toxin type A for facial wrinkles. Cochrane Database of Systematic Reviews. 2021. https://pubmed.ncbi.nlm.nih.gov/34224576/ [4] Ministry of Food and Drug Safety (Korea). Biological Products: Hugel, Inc. https://www.mfds.go.kr/eng/brd/m_30/view.do?seq=69800 [5] Hugel, Inc. HUGEL. https://www.hugel-inc.com/en/solution/brands For licensed healthcare professionals only. This content is for informational purposes only and does not constitute medical advice.